Immunosuppressive Therapy for Heart Failure: A Guide to Patient Selection

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.5, 2003-01, pp. : 321-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Modulation of Cardiovascular Remodeling: A Guide to Heart Failure Therapy

By Remme W.J.

Cardiovascular Drugs and Therapy, Vol. 17, Iss. 4, 2003-07 ,pp. : 349-360

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Therapy of Heart Failure

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2582-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Therapy of Chronic Heart Failure

By Hamad Eman Mather Paul J. Srinivasan Siva Rubin Sharon Whellan David J. Feldman Arthur M.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

-Blocker therapy in heart failure reviewed

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Tailored therapy for heart failure: neurohormones

By Richards A. Mark

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 8, 2011-08 ,pp. : 603-607

NRC Research Press

Access to resources Recommend Favorite